Iniparib (BSI-201) (C007B-036600)

Iniparib (BSI-201) is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC).Iniparib (BSI-201) is an antineoplastic originally thought to be a poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor. Recent studies indicate Iniparib is not a PARP-1 inhibitor, and its mechanism of action is currently unknown. Specification: ≥98% Molecular Formula: C7H5IN2O3 Molecular Weight: 292.03 PubChem CID: 9796068 Isomeric SMILES: C1=CC(=C(C=C1C(=O)N)[N+](=O)[O-])I Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/B125751-SCI_3c96d792b6c085e491d1c7dc3873802a.pdf

UPC:

12352200

Condition:

New

Weight:

0.96 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

B125751-10mg

CAS:

160003-66-7

Product Size:

10mg

Hazard Statement Codes:

H302:H319

Precautionary Statement Codes:

P264:P270:P280:P330:P301+P312:P305+P351+P338:P501